Ligand Pharmaceuticals Stock Price. Everything You Need To Know About The Ligand Pharmaceuticals Stock!
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. The company is headquartered in San Diego, California and currently employs 76 full-time employees. The firm is focused on acquiring or funding programs and technologies that pharmaceutical companies use to discover and develop medicines. The Company’s Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Its Pelican Expression technology is a scalable platform for recombinant protein production, and is especially suited for complex, large-scale protein production. The Company’s products include Kyprolis, Teriparatide, Evomela, Rylaze, Nexterone, Pneumosil, Vaxneuvance, and Other. Kyprolis is formulated with Ligand’s Captisol technology. Teriparatide Injection is a drug indicated for uses including the treatment of osteoporosis in certain patients at high risk for fracture. Evomela is a Captisol-enabled melphalan IV formulation. Its other products include Pneumosil, Rylaze, Nexterone, Veklury, Zulresso, and Noxafil-IV.
Ligand Pharmaceuticals Stock Price. Everything You Need To Know About The Ligand Pharmaceuticals Stock! performance
- Employees 76
- Company HQ San Diego
- Website https://www.ligand.com/
- LGND Asset Type Common Stock
- LGND Market Capitalization 1.3B
- Earnings Per Share 3.03
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth -0.975
Looking to invest in Ligand Pharmaceuticals from Malaysia, Thailand, Indonesia, or Vietnam? Look no further. At Zorion, we provide retail investors in these countries with the opportunity to invest in real US stocks, including Ligand Pharmaceuticals. As a leading investment platform, we offer valuable investment insights and recommendations to help investors make informed decisions. Additionally, Zorion provides access to a wide range of educational resources and materials to further your investment knowledge. With Ligand Pharmaceuticals, you can tap into the potential of the biopharmaceutical industry and diversify your investment portfolio. Join Zorion today and start investing in Ligand Pharmaceuticals with confidence.
